Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT03412344
  4. Details
NCT03412344 Clinical Trial

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

Cancer Clinical Trial

Official title:
Assessing Knowledge and Affecting Factors Associated With Cancer Patients Participation in Clinical Trials in China.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03412344
Other study ID # CH-HUR-004
Secondary ID
Status Recruiting
Phase N/A
First received December 29, 2017
Last updated January 20, 2018
Start date July 15, 2017
Est. completion date December 2018

Study information
Verified date January 2018
Source Chinese Academy of Medical Sciences
Contact Shiyu Jiang, MD
Phone +86 13121700970
Email 309615685@qq.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This research studies factors affecting Chinese patient participation in cancer clinical trials and their knowledge regarding clinical trials. The investigators design this study to determining how patients makes decisions about participating in a clinical trial and know about patients' attitude toward clinical trials. The investigators aim to find ways to make cancer clinical trials in China more efficient and satisfied patients participating in clinical trials in China.

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date December 2018
Est. primary completion date August 2018
Accepts healthy volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of malignancy

- Aged 18 years or older

- Ability to understand and complete the questionnaire independently or with the help of a relative or staff member of the oncology department

- Patients have been consented to join an oncology treatment clinical study and have begun active treatment of an oncology clinical trial

Exclusion Criteria:

• Not meeting all eligibility criteria

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing Beijing

Sponsors (1)
Lead Sponsor Collaborator
Chinese Academy of Medical Sciences

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary The patient related factors and the doctor related factors that influence patient decision regarding participation in a cancer clinical trial will be explored by questionnaire. 1 year
Secondary Oncology patients' understanding and attitude of clinical trials towards cancer clinical research will be evaluated by questionnaire. 1 year
Secondary The actual experience of participants in a cancer clinical trial will be investigated by questionnaire. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases